Skip to main content
← All trials
Stage IV Non-small Cell Lung CancerBehavioralBehavioral

What this study is

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC). The main questions are

  • is POISE feasible to deliver and acceptable to patients
  • what is the effect of POISE on the distress patients feel related to their uncertain future, their confidence in their ability to manage cancer, and their understanding about what to expect Participants in the randomized controlled trial will receive either the new supportive care model, POISE, which consists of four visits with a trained palliative care clinician, or care as usual, and will be asked to complete three surveys.

What's being tested

  • POISE

    Intervention · BEHAVIORAL

    POISE (Patient-centered, Optimal Integration of Survivorship and palliative carE) is a brief, population-specific intervention that consists of four sessions with palliative care specialists who have been additionally trained to evaluate and address the specific psychosocial issues and health-promoting behaviors of patients with long, uncertain cancer trajectories.

Study details

Sponsor
Massachusetts General Hospital
Conditions
Stage IV Non-small Cell Lung Cancer · Targeted Therapy · Nonsmall Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · ALK-positive Non-small Cell Lung Cancer · EGFR Positive Non-small Cell Lung Cancer · Palliative Care · Survivorship
Enrolling
70 people
Starts
2023-09-29
Est. completion
2027-09-01
Design
Single-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗